

Felix Scholkmann
5.3K posts

@FScholkmann
Researcher/Lecturer@UZH_ch | Neurophotonics, functional neuroimaging, integrative human physiology, biophysics, signal processing, physics, philosophy and more



JAMA Psychiatry just published a trial that should make everyone rethink how we treat depression. A single day of inhaled psychedelic [mebufotenin (GH001)] produced 57.5% remission in treatment-resistant depression. The placebo group? 0%. Here's why this matters:





















Myelin: A possible proton capacitor for energy storage during sleep & energy supply during wakefulness sciencedirect.com/science/articl… New publication together with A.M. Morelli & A. Saada (@annsaada) • A new hypothesis as to why living organisms need sleep #neuroscience #biophysics








Myelin: A possible proton capacitor for energy storage during sleep & energy supply during wakefulness sciencedirect.com/science/articl… New publication together with A.M. Morelli & A. Saada (@annsaada) • A new hypothesis as to why living organisms need sleep #neuroscience #biophysics


